4//SEC Filing
Cameron Kevin J 4
Accession 0001114220-18-000066
CIK 0001114220other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 4:13 PM ET
Size
4.8 KB
Accession
0001114220-18-000066
Insider Transaction Report
Form 4
Cameron Kevin J
Director
Transactions
- Sale
Common Stock
2018-06-18$4.98/sh−1,667$8,302→ 176,666 total
Footnotes (2)
- [F1]Sale of a total of 1,667 shares of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2017.
- [F2]Includes 9,999 shares of restricted stock.
Documents
Issuer
KERYX BIOPHARMACEUTICALS INC
CIK 0001114220
Entity typeother
Related Parties
1- filerCIK 0001398422
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 4:13 PM ET
- Size
- 4.8 KB